@kainvests · Long IOVA · The Analysts

Call · @kainvests · #8 on the leaderboard

@kainvests

@kainvests · Tue, Sep 15

$IOVA Iovance Biotherapeutics is once again being mentioned as a potential M&A target, this time for Johnson & Johnson and Pfizer: https://t.co/UjOsmmR4Rg We don't know whether Iovance is for sale, but we do know that it is on many big pharmas' radar. The thesis is simple:

3d agoview on X ↗

tweeted Tue, Sep 15 · counted from Wed, Sep 16 close

Read as

Long IOVA · High confidence

Confidence

High0.90

Counted from

Wed, Sep 16 · market close

Rank since this call

—

Sep 16

Sep 17

Leaderboard position per scored day, never a price chart. Other calls were active in this window; no single call is credited.